In the period 1971-81, more than 1.9 million persons were registered with a malignant neoplasm among the 49.2 million population of England and Wales. For 63,536 people, two or more tumor registrations (multiple tumor records) have arisen in that period. Because of the structure of the National Cancer Registration scheme, some errors in registration are inevitable, particularly duplicate registration of a single tumor by adjacent regional cancer registries. A pilot study showed that 61 percent of multiple records would represent true multiple primary malignancy, and that these records could be readily separated from registration errors.
INTRODUCTION
The study of multiple primary malignant neoplasms may provide information relevant both to the etiology and to the management of cancer [1] . In discussing the incidence of bilateral breast tumors, Prior and Waterhouse [2] comment that "knowledge of absolute and differential rates of second primary tumours is not only of great clinical importance for the future management of the breast cancer patient, but might give some clues to the aetiology of the disease itself'; their remark has a wider relevance for second malignancies in general.
Two malignant tumors arising in one individual may share a common genetic predisposition, as with retinoblastoma, or a common environmental etiology, as with bladder and respiratory tract tumors associated with the use of tobacco. Studying the association of two or more tumors in multiple primary neoplasia may therefore offer new clues to the etiology of cancer. The management of patients with one tumor may also be improved if those at highest risk of a second tumor can be identified from such studies, leading to appropriate surveillance and earlier, more effective treatment for the second tumor. The therapy for a first tumor has itself been recognized as an important cause of second primary neoplasms [3, 4] : study of multiple primary tumors may be expected both to improve the choice of therapy for a first tumor and to identify the most probable site or type of a second primary for the purposes of surveillance.
The occurrence of two or more primary neoplasms in one individual may also be the result of chance. Study of this condition therefore requires access to a large body of data, because only a small proportion (perhaps 1 in 20) of patients with one malignancy will be expected to develop a second. In attempting to derive unbiased estimates of the incidence of second tumors, the individuals studied should be an unbiased sample-preferably a complete (100 percent) sample-of the population with a first tumor. A series of patients treated at a large hospital specializing in cancer therapy is unlikely to be representative of cancer patients as a whole, whether for site or stage of disease, or for other prognostic factors, unless the hospital treats all cancer patients in its territory.
Population-based data on the incidence of second malignancies remain scanty. Schoenberg [5] has provided evidence from the Connecticut Tumor Registry that patients with one cancer have 1.29 times the risk of developing a new primary cancer compared with individuals who never had cancer, studying over 5,000 second tumors registered in 30 years ) among 121,000 cancer patients. The risk was 1.37 for females and 1.20 for males. A study of 5,300 second cancers observed among 180,000 women treated for cervix cancer and registered at one of 15 population-based regional or national registries has been reported [6] . Recently Teppo et al. [7] reported 5,000 second cancers among nearly 280,000 cancer patients registered in the Finnish Cancer Registry from 1953-79. They noted an inverse relation between second tumor risk and age at first cancer, and the risk in females (1.09) was higher than for males (0.89), but their overall risk (0.99) did not confirm the overall result from the Connecticut Registry.
In England and Wales, fourteen' population-based regional cancer registries have covered the entire population since 1962 (Fig. 1) This pilot survey showed that at least 64 percent of all the multiple records could be expected to be multiple primary neoplasms, and that most registration errors could be removed using criteria applicable within a computer program.
Four key identifiers (year of registration, code identifying the registry, tumor serial number within that registry, and anniversary date of the tumor) were abstracted from each tumor registration in each multiple record and entered into a computer file. A new multiple tumor number was automatically assigned to each tumor, consisting of a serial number from 1 to N, with a terminal digit representing the ordinal rank (1st, 2nd, 3rd, and so on) of each tumor within each multiple record. The resulting file, containing 63,536 multiple tumor records involving 129,047 registrations, was then sorted into the same sequence as the national cancer file and matched against it (Fig.  3) . Three files resulted. Where all four identifiers on a tumor from a multiple record matched perfectly with a tumor on the national file, all the data on that tumor were extracted. Tumors from the multiple file for which a perfect match could not be found were stored separately. For tumors on the national file not involved in a multiple record, sufficient data were extracted to derive the person-years3 at risk of a second tumor. Individuals were censored on reaching their hundredth birthday, if this preceded death, emigration, or the end of the study period on 31 December 1981.
Multiple records for which all component tumor registrations were successfully matched to an extant registration on the national cancer file were submitted to two further sets of checks. First, they were searched for probable errors of registration or linkage, using criteria derived from the pilot study. For example, multiple records involving two regional registries were excluded (unless they had previously been edited at OPCS to remove duplicates) because the pilot study had shown that only 8 were likely to represent multiple primary malignancy. Next, the records were checked with an algorithm designed to apply the Surveillance, Epidemiology and End Results program (SEER) criteria for multiple primary malignancy [ 1] . For this purpose, site was defined at the three-digit level of the eighth revision of the International Classification of Diseases (ICD) [12] , after conversion [13] of ninth revision codes [14] for 1979-81. Records in which one or both of the tumors had been assigned a non-specific site-code (195-9) were excluded. For colon, rectum, bone, connective tissue and skin, site was defined at the four-digit level. Histology was defined at the three-digit level. A simplified schema of the algorithm used to apply these checks and exclusions is given in Fig. 4 .
Expected numbers of second tumors were calculated by multiplying the age, sex, and calendar year-specific incidence rate for the second cancer site of interest by the person-years accrued by individuals with the first cancer within the same categories of age, sex, and time, then summing across all age groups and calendar years. Expected numbers are then compared with the observed number of second tumors. The result is a set of relative risks (observed/expected) for a particular second tumor among those with a given first tumor, for each sex and for each combination of two tumor sites, adjusted for age, calendar time, and survival from the first tumor. Such results can be examined separately for various time periods since each subject's first tumor (the interval at risk of a second tumor) to see if second cancer risk changes as survival increases.
The assumption underlying such calculations is that the risk of a tumor does not change appreciably within the age strata used; five-year age intervals are sufficiently small for this purpose for most tumors, but infants under one year of age are considered separately. Under the null hypothesis that the two tumors are rare independent events, the number of observed tumors can be treated as a random variable drawn from a Poisson distribution with mean equal to the expected number. The significance of any excess of observed tumors is assessed accordingly. (Table 2) , either because the tumor registration(s) had been previously cancelled or because of keying errors in preparation of the multiple file. These records will be reviewed in due course but are not considered further here. For a further 5,766 multiple records, one or more tumor registrations was successfully matched and extracted, but at least one was not. These records contain defective sequences of tumors (1-3; 2-3, and so on) and are also excluded from further consideration here.
A total of 56,678 multiple tumor records were fully matched to extant registrations on the national cancer file. These were further edited using the algorithm (Fig. 4) . Different sex codes were found within 207 multiple records: these were excluded as possible linkage errors (Table 2 ). Records involving two or more registries were also excluded (see Methods). About 400 (8 percent) true multiple primaries may have been rejected among the 5,291 records in this category: they will be retrieved for analysis after further checks have been carried out. Almost 2,000 records involving a first or second tumor site-coded to 195-9 (ill-defined or secondary neoplasms) were excluded. Nearly 3,000 further records were rejected on the basis of SEER criteria involving site, histology, and time, and a further 54 because one of the first two tumors was coded as metastatic.
After removal of 10,523 records in this way, 46,155 multiple tumor records were considered acceptable for further analysis as multiple primary malignancies. These records contained two or more tumors satisfying the SEER definition of multiple primary malignancy, summarized in Table 3 .
The distribution of first and second tumors by year of occurrence is shown in Table  4 . The largest number of second tumors occurs in the same year as the first, with a gradual decline in successive years. More than a third of all second tumors arise in the same calendar year as the first, but this is largely a function of the relatively short follow-up (1 1 years at most), and the proportion falls to one-sixth where up to ten years of follow-up are available. This pattern appears more clearly in Table 5 , where the number of second tumors arising with a given delay since the first tumor is seen to be fairly stable, regardless of the calendar year in which the first tumor was registered.
The distributions of first and second tumors in a multiple primary by broad site-group and by individual site are given in Tables 6 and 7 , respectively. First tumors in a given site-group or site may be linked with second tumors at any site, and vice versa: thus over 7,700 tumors of the digestive tract were observed as first tumors in a multiple primary followed by a second tumor at any site, while more than 11,000 tumors of the digestive tract occurred as second tumors, preceded by a first tumor at any site. These tables show that considerable numbers of multiple tumors are available for study at most sites: for example, more than 1,100 second leukemias.
Person-years at risk of a second tumor were accrued by almost 1.9 million individuals: their distribution by sex and by time since diagnosis of the first tumor is given in Table 8 . Excluding the first twelve months since diagnosis, more than 2.75 million person-years were observed, almost three-quarters (73 percent) of these before the fifth anniversary of diagnosis of the first tumor. Only 16,000 person-years were accrued beyond the tenth anniversary: all these would be in subjects whose first tumor was diagnosed in 1971 and survived until some time in 1981 or beyond. At this stage, therefore, the available information on second cancer risk beyond ten years of follow-up will be scanty.
Results for second malignant tumors at any site (ICD-8 140-209) following a first malignant tumor at any site are presented in Table 9 , for males and females up to the age of 84. Simultaneous tumors are excluded from this table (2,717 and 2,371 for males and females, respectively). A total of 11,159 second tumors were observed in males at least 12 months after the first tumor, against 14,424.5 expected, an overall risk of 0.77. Among females, there were 9,538 observed against 11,883.6 expected second tumors between one and 11 years after the first tumor, an overall risk of 0.80. For both sexes, the second tumor risk exceeded unity in the twelve months immediately after diagnosis of the first tumor and was less than unity thereafter. For each sex, there is a downward trend of second cancer risk with time. Each individual risk estimate is significantly different from unity (p < 0.01) and each time trend is also significant (p < 0.001). DISCUSSION Review of a 1 percent random sample of an estimated 44,800 multiple tumor records arising in England and Wales during the period [1971] [1972] [1973] [1974] [1975] [1976] [1977] [1978] [1979] [1980] had shown that 64 percent could be expected to represent multiple primary malignancy; the proportion would be much higher (86 percent) among multiple records for which all the tumors originated from a single registry. The review also showed that more than 100,000 such records had arisen by the end of 1984, and that it would be feasible to separate registration errors from multiple primary cancers [1 5] . Data were extracted from national cancer files for more than 56,000 complete sequences of tumors, of which 46,155 appear to be multiple primary malignancies. The distribution of these tumors by site and by time is consistent with what would be expected for multiple primary malignancies. To be included in the data, both the first and the second tumor had to be registered in the 1 1-year interval 1971-81. During that period there was a steady decline in the annual number of first tumors involved in a multiple primary by 1981 (Fig. 5 ). There was a parallel increase in the annual number of second tumors, as the total population at risk of a second tumor since 1971 gradually increased ( Table 4) .
The pattern of occurrence by year and by period at risk (Tables 4 and 5) suggests 'Excluding first year of follow-up. that about 4,600 multiple primaries were being recorded each year by 1981, and that this figure will increase by perhaps 200 a year for several more years. It would be expected to stabilize only when all prevalent cases of cancer have been diagnosed since 1971. The multiple tumor data studied here originated as a spin-off from the acquisition of passive survival data by flagging of cancer patients at NHSCR. As such, the linkage of two tumors to one individual has been carried out without the detailed checks made by many individual registries with an interest in multiple primary malignancy. Whilst this carries disadvantages, such as the need to exclude administrative errors of registration, there is at least one compensation. It may be an advantage to hold multiple records which would be considered as multiple primary malignancy by some criteria, but not Anniversary Year by others. The data do not depend on the past application of criteria which might now be considered inappropriate. New or alternative sets of criteria can be applied to the entire data set in order to demonstrate any differences in recorded incidence which their application would be likely to produce. Equally, but on a more parochial note, systematic examination of the errors of registration detected in this study will be expected to lead to improvements in the National Cancer Registration scheme. Since flagging only began in 1971, any second cancers arising since then in individuals with a previous, unflagged cancer registered before 1971 will not have been linked to the prior tumor. The proportion of second cancers undetected for this reason will be expected to decay steadily, reaching zero when all surviving cancer patients have been registered since 1971, and flagged. For many cancers, survival beyond 10 or 12 years is still uncommon, and the OPCS multiple records may already be expected to contain virtually all second cancers that have been registered.
The overall risk of a second tumor is not raised, a result which is consistent with those recently reported from Finland [7] and Denmark [Storm et al., this issue], but at odds with results from Connecticut [Boice et al, this issue]. The downward trend of second cancer risk with time since diagnosis of the first tumor was unexpected and is opposite to the trends reported from all three registries mentioned above, although none of the trends is large. Possible explanations include under-registration of second cancer, particularly for patients diagnosed in the early 1970s when there may have been less awareness of multiple tumors, and less readiness to attach a new tumor diagnosis to the patient's record for ultimate abstraction by registry staff. The Danish study cited above has suggested that under-registration there may have resulted in up to 20 percent reduction in observed second-cancer risk. It is also possible that efficiency of linkage between two tumors at NHSCR has improved since flagging of tumor registrations began in 1971. Up to 14 percent of multiple primaries may also have been excluded from the data by the automatic editing processes described here. Inclusion of these records will require additional checks on the accuracy of the data. Finally, mortality data for cases registered in 1971 and 1972 is now known to have been complete only up to October 1981: the use of 31 December 1981 as the end of study date for these subjects will have resulted in overestimation of person-years at risk, and a corresponding reduction in risk (O/E) at 10+ and 9+ years, respectively. Further analysis will now be done to explore links between specific pairs of primary sites, after refinement of the criteria used to distinguish multiple primaries from duplicate registrations. The OPCS data on multiple primary malignant neoplasms should be particularly valuable for the study of more recently introduced therapeutic regimes for a first primary cancer, because the large volume of data will enable precise risk estimation, to compensate in part for the relatively short duration of follow-up.
